13F HOLDINGS REPORT
Omega Fund Management, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950123-23-005263
Total Value
$153.3M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Replimune Group | REPL | 3,050,187 | $53.9M | 35.13% |
| 2 | Nuvation Bio | NUVB | 15,072,340 | $25.0M | 16.32% |
| 3 | Morphic Holding | 61775R105 | 597,723 | $22.5M | 14.67% |
| 4 | Alpine Immune Sciences | 02083G100 | 2,029,580 | $15.7M | 10.22% |
| 5 | Ikena Oncology | 45175G108 | 2,249,123 | $7.8M | 5.06% |
| 6 | Theseus Pharmaceuticals | 88369M101 | 711,479 | $6.3M | 4.12% |
| 7 | Kronos Bio | 50107A104 | 3,818,283 | $5.6M | 3.64% |
| 8 | Paratek Pharmaceuticals | 699374302 | 1,971,241 | $5.0M | 3.27% |
| 9 | Spruce Biosciences | SPRB | 2,161,022 | $4.8M | 3.11% |
| 10 | Sana Biotechnology, Inc. | SANA | 843,750 | $2.8M | 1.80% |
| 11 | Immunic Inc | IMUX | 1,788,160 | $2.7M | 1.74% |
| 12 | Syros Pharmaceuticals | 87184Q206 | 251,270 | $670,891 | 0.44% |
| 13 | Jounce Therapeutics | 481116101 | 275,513 | $509,699 | 0.33% |
| 14 | Senti Biosciences, Inc. | SNTI | 195,792 | $231,035 | 0.15% |